HEALTHTECH SOLUTIONS INC. Financials Healthtech Solutions Inc.
Equities
HLTT
US42227P1030
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 USD | -97.37% |
|
-.--% | -.--% |
| 2023 | Healthtech Solutions Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2023 | Healthtech Solutions Inc. Auditor Raises 'Going Concern' Doubt | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 0.6888 | 43.53 | 20.94 |
| Enterprise Value (EV) 1 | 0.8655 | 43.86 | 24.21 |
| P/E ratio | -0.12 x | -2.1 x | -6.49 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | 1,24,09,037 x |
| EV / Revenue | - | - | 1,24,09,039 x |
| EV / EBITDA | -1.03 x | -8.74 x | -6.2 x |
| EV / FCF | -2.6 x | 173 x | -13.3 x |
| FCF Yield | -38.4% | 0.58% | -7.51% |
| Price to Book | -1.22 x | -67.2 x | -7.61 x |
| Nbr of stocks (in thousands) | 9,701 | 66,966 | 72,216 |
| Reference price 2 | 0.0710 | 0.6500 | 0.2900 |
| Announcement Date | 02/03/21 | 15/04/22 | 28/06/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net sales | - | - | - | - | 1.688 |
| EBITDA | - | -0.5098 | -0.671 | -4.979 | -3.379 |
| EBIT 1 | -0.6313 | -0.5487 | -0.7099 | -5.005 | -3.457 |
| Operating Margin | - | - | - | - | -204.85% |
| Earnings before Tax (EBT) 1 | -0.6313 | -0.5487 | -0.7322 | -8.306 | -3.457 |
| Net income 1 | -0.6313 | -0.5487 | -0.7322 | -9.109 | -3.044 |
| Net margin | - | - | - | - | -180.34% |
| EPS | - | - | -0.6110 | -0.3095 | -0.0447 |
| Free Cash Flow | - | -0.1682 | -0.2644 | 0.251 | -1.573 |
| FCF margin | - | - | - | - | -93.22% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 16/11/20 | 16/11/20 | 02/03/21 | 15/04/22 | 28/06/23 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net Debt | - | - | 0.18 | 0.33 | 3.27 |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | -0.2633 x | -0.0662 x | -0.9677 x |
| Free Cash Flow | - | -0.17 | -0.26 | 0.25 | -1.57 |
| ROE (net income / shareholders' equity) | - | -248% | 342% | 1,373% | 186% |
| ROA (Net income/ Total Assets) | - | -138% | -264% | -1,064% | -136% |
| Assets 1 | - | 0.3963 | 0.2768 | 0.8561 | 2.236 |
| Book Value Per Share | - | - | -0.0600 | -0.0100 | -0.0400 |
| Cash Flow per Share | - | - | 0.0100 | 0 | 0 |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 16/11/20 | 16/11/20 | 02/03/21 | 15/04/22 | 28/06/23 |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 51.56T | |
| +9.22% | 3.39TCr | |
| +21.99% | 835.06Cr | |
| +31.37% | 423.8Cr | |
| -30.15% | 267.31Cr | |
| -19.11% | 145.39Cr | |
| -28.03% | 132.5Cr | |
| -33.21% | 116.36Cr | |
| +13.85% | 100.33Cr | |
| -34.50% | 89Cr |
- Stock Market
- Equities
- HLTT Stock
- Financials Healthtech Solutions Inc.
